Tetsuya Takada, RPh., MBA

Director, Business Development Japan at KD Pharma Group
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Hyogo, Japan, JP
Languages
  • English Full professional proficiency
  • Japanese Native or bilingual proficiency
  • English Native or bilingual proficiency
  • Japanese Native or bilingual proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

5.0

/5.0
/ Based on 2 ratings
  • (2)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

Mark Allman

Since 2005 Takada-san has provided sound advice on market entry strategies, made important introductions and worked with me to represent g-Nostics' interests in Japan. His network of movers and shakers in the Japanese marker is second to none and he networks with ease to build his network. Ted is a knowledgable consultant, a great mentor, and a great friend.

Mary J. Ortner, PhD, MBA

Tetsuya (Ted) was a great partner in assisting my company find clients in Japan and in doing business there. Over several years collaboration, he personally accompanied me to several meetings in Japan where I gave presentations to top pharmaceutical companies. He was invaluable in securing their business for our company. I have known Ted for many years and found him to be a very sophisticated international player, well experienced in the US and Europe. I highly recommend him as a business partner and a friend.

You need to have a working account to view this content.
You need to have a working account to view this content.

Credentials

  • Pharmacist
    Ministry of Health, Labor and Walefare Japan
    Apr, 1987
    - Nov, 2024

Experience

    • Switzerland
    • Pharmaceutical Manufacturing
    • 100 - 200 Employee
    • Director, Business Development Japan
      • Dec 2022 - Present

  • TIPharms & Company, Co., Ltd.
    • Greater Osaka, Japan
    • President
      • Sep 1992 - Present

    • United States
    • Business Consulting and Services
    • 700 & Above Employee
    • Project manager for technology transfer, RA, CMO management
      • Oct 2021 - Oct 2022

  • Alvis Inc.
    • Tokyo, Japan
    • Business Development and QA and RA Professional (fixed-term/project basis)
      • Mar 2019 - Nov 2019

    • Senior Executive Consultant (fixed term/project basis)
      • Sep 2018 - Feb 2019

    • United States
    • IT Services and IT Consulting
    • 700 & Above Employee
    • Director, Business developemnet for Pharmacovigilance
      • Feb 2017 - May 2018

    • Business Consulting and Services
    • 100 - 200 Employee
    • Sr. QA Professional (Project basis contract, third-party QA auditor)
      • Feb 2012 - Dec 2016

    • South Africa
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Consultant
      • Feb 2015 - Feb 2016

    • United Kingdom
    • IT Services and IT Consulting
    • 700 & Above Employee
    • Executive Director for Biotech/Pharmaceutical/Healthcare Industry sector
      • Dec 2012 - Dec 2014

    • Switzerland
    • Pharmaceutical Manufacturing
    • 500 - 600 Employee
    • Head of Japan Regional Office
      • Jan 2011 - Dec 2011

    • Business Development Consultant (contract)
      • 2008 - 2009

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Executive Director, Corporate Strategic Planning
      • Oct 2007 - Jul 2008

    • Ireland
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Business Development Manager, consultant
      • Apr 2004 - Dec 2007

    • Pharmaceutical Manufacturing
    • 300 - 400 Employee
    • Business Development Manager, consultant
      • Apr 2002 - Nov 2007

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Senior Liaison Officer
      • Jul 1991 - Sep 1992

Education

  • Nihon Universty, Graduate School of Business
    MBA
  • University of Florida
  • University of Wisconsin-Stevens Point
    B.S.
  • Tokushima Bunri University
    B.Pharm
    1979 - 1983

Community

You need to have a working account to view this content. Click here to join now